These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19940480)

  • 1. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.
    Gutiérrez-Galve L; Lehmann M; Hobbs NZ; Clarkson MJ; Ridgway GR; Crutch S; Ourselin S; Schott JM; Fox NC; Barnes J
    Dement Geriatr Cogn Disord; 2009; 28(5):476-85. PubMed ID: 19940480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
    Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
    Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
    Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
    Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
    Wolk DA; Dickerson BC;
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
    Singh NA; Tosakulwong N; Graff-Radford J; Machulda MM; Pham NTT; Sintini I; Weigand SD; Schwarz CG; Senjem ML; Carrasquillo MM; Ertekin-Taner N; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Alzheimers Dement; 2023 Mar; 19(3):784-796. PubMed ID: 35691047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.
    Taylor JL; Scanlon BK; Farrell M; Hernandez B; Adamson MM; Ashford JW; Noda A; Murphy GM; Weiner MW
    Neurobiol Aging; 2014 Nov; 35(11):2479-2485. PubMed ID: 24929969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
    Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
    Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
    Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
    J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults.
    Van Etten EJ; Bharadwaj PK; Hishaw GA; Huentelman MJ; Trouard TP; Grilli MD; Alexander GE
    Hippocampus; 2021 May; 31(5):469-480. PubMed ID: 33586848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family history of Alzheimer's disease and hippocampal structure in healthy people.
    Donix M; Burggren AC; Suthana NA; Siddarth P; Ekstrom AD; Krupa AK; Jones M; Martin-Harris L; Ercoli LM; Miller KJ; Small GW; Bookheimer SY
    Am J Psychiatry; 2010 Nov; 167(11):1399-406. PubMed ID: 20686185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers.
    Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y
    Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Cacciaglia R; Molinuevo JL; Falcón C; Brugulat-Serrat A; Sánchez-Benavides G; Gramunt N; Esteller M; Morán S; Minguillón C; Fauria K; Gispert JD;
    Alzheimers Dement; 2018 Jul; 14(7):902-912. PubMed ID: 29605385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.
    Manning EN; Barnes J; Cash DM; Bartlett JW; Leung KK; Ourselin S; Fox NC;
    PLoS One; 2014; 9(5):e97608. PubMed ID: 24878738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.